Endometrioma Ethanol Sclerotherapy - Prospective Cohort Study Protocol

ConditionsIVFEndometrioma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-41
SponsorHillel Yaffe Medical Center

About this trial

Ovarian endometriomas are cystic masses lined with endometrial tissue that contains fluid arising from a collection of menstrual debris. Ovarian endometriomas clinical manifestations includes pelvic pain, dysmenorrhea, dysfunctional uterine bleeding, and infertility.

Endometriomas are most commonly treated either medically or by surgical excision.

Ultrasonography (US)-guided aspiration and sclerotherapy is a new approach. Its mechanism of action is believed to be destruction of the inner epithelial lining, which is followed by inflammation and fibrosis, eventually resulting in regression of the cyst. The main advantage in this approach is the avoidance of collateral damage to the ovary.

Eligibility criteria

Qualifiers

None

Disqualifiers

Other causes of infertility (sperm disorder, ovulation disorder, uterine disorder, mechanical factor, poor ovarian reserve)

Trial design

Treatments tested in this trial

  • Sclerotherapy

Treatment groups

120 Participants
are divided into 1 treatment group

Sponsors and collaborators